GH
Guardant Health, Inc.
Guardant Health (GH) is a commercial-stage precision oncology company focused on blood-based cancer detection tests, with a single congressional purchase ($1,001-$15,000) representing its only direct political signal.
Govt Dependence
1/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat GH does
Guardant Health develops and commercializes blood-based tests for cancer screening, treatment selection, and recurrence monitoring. Its revenue is primarily derived from its Guardant360 tissue biopsy test and its Guardant Reveal minimal residual disease test, with a growing focus on its Shield colorectal cancer screening test. The company operates in a highly regulated diagnostic and reimbursement environment.
12 months past · 3 months futureGH activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
1 congressional trades shown
·
0 insider buys
·
15 13F filings
·
0 past bill actions
·
16 upcoming markups
Lifetime Government AwardsGH federal contracts by year
$14K
total awarded · 2021–2021
1
contracts on file
2021
peak year ($14K)
Top contracts by award amount
$14K
Department of Health and Human Serv
2021-09-20
LABORATORY TESTING
1 years · 1 contracts
Smart Money · 13F HoldingsHedge funds holding GH
$1.87B
Total GH held by tracked 13F funds
40
Funds with GH positions
+40
Funds opened this quarter
Two Sigma Investments
$222M
opened
1 overlap
2025-12-31
Citadel Advisors
$153M
opened
2025-03-31
Citadel Advisors
$152M
opened
2025-06-30
Two Sigma Investments
$113M
opened
2025-09-30
Two Sigma Investments
$97M
opened
2025-06-30
D.E. Shaw & Co.
$95M
opened
1 overlap
2025-12-31
Citadel Advisors
$85M
opened
2024-06-30
D.E. Shaw & Co.
$83M
opened
2025-09-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading GHMembers of Congress with recent GH positions
1 politicians traded GH across 1 disclosed transactions totaling $8K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just GH). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading GH
2025-11-21
Sheldon Whitehouse
Purchase
$1,001 - $15,000
2022-02-28
Donald S. Beyer
Sale
$1,001 - $15,000
2022-02-28
Donald S. Beyer
sale
$1,001 - $15,000
2022-01-13
Donald S. Beyer
Sale
$1,001 - $15,000
2022-01-13
Donald S. Beyer
sale
$1,001 - $15,000
2021-12-22
Donald S. Beyer
sale
$1,001 - $15,000
2021-12-22
Donald S. Beyer
Sale
$1,001 - $15,000
2020-11-02
Donald S. Beyer
Purchase
$1,001 - $15,000
2020-11-02
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-05
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-22
Donald S. Beyer
purchase
$1,001 - $15,000
2020-10-05
Donald S. Beyer
Purchase
$1,001 - $15,000
21+ trades on file · most recent 2025-12-01
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
19
option exercises · $439K
For GH, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting GHLive legislation impacting this stock
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
HR.920 · 119th
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
HR.679 · 119th
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strate
S.708 · 118th
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
S.574 · 118th
Increasing Prescription Drug Competition Act
S.669 · 118th
Increasing Mental Health Options Act of 2023
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
Political ProfileWhere GH sits in Washington
[object Object]
STRUCTURAL: No lobbying spend (`get_political_influence.lobbying.total_income`: $0), no donations, minimal federal contract exposure ($14,000). EVIDENTIARY: One congressional purchase (Rep. Roger Williams, $1,001-$15,000) and no corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys`: 0). Net: Minimal direct political engagement; primary exposure is regulatory via healthcare legislation.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Reimbursement rate changes and coverage determinations for liquid biopsy tests.Centers for Medicare & Medicaid Services (CMS)"High `regulatory_density_score` (85) and sector classification (healthcare) imply primary regulatory risk from CMS."
Regulatory opportunities
-
Expansion of Medicare coverage for colorectal cancer screening via blood tests.Centers for Medicare & Medicaid Services (CMS)"Sector classification (healthcare) and business model focused on screening indicate CMS coverage decisions are a primary opportunity vector."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Member intelligence layer
Live signals + predictions for GH — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades GH
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout GH & political exposure
Does Guardant Health, Inc. (GH) hold federal contracts?
Yes. Guardant Health, Inc. has 1 federal contract awards totaling $14,000, primarily from agencies including Department of Health and Human Services. See full contract list and amounts on this page.
Has Congress traded GH stock?
21 congressional trades by 2 unique members of Congress, most recently on 2025-11-21. See the Congressional Trading panel for politician-by-politician breakdown.
What is GH political risk profile?
Government dependence: 1/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track GH political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. GH data is updated daily from these official federal sources.